Some Experimental Models of Liver Damage

Hepatotoxicity: From Genomics to in vitro and in vivo Models

Volumn , Issue , 2008, Pages 119-137

  Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Acute and chronic lesions; Anatomical proximity; Fatty acid molecules; Gastrointestinal organs; Hepatic artery and portal vein; Hepatic histopathology; Hepatic injury experimental models; Metabolic and biochemical transformation; Nucleolar and nuclear abnormalities and megalocytes; Potential hepatotoxic effects

Indexed keywords

EID: 84889399430     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470516751.ch6     Document Type: Chapter

References (123)

1. Agarwal M., Srivastava V. K., Saxena K. K., and Kumar A. (2006). Hepatoprotective activity of Beta vulgaris against CCl4-induced hepatic injury in rats. Fitoterapia 77: 91-93.
2. Albano E., Bellomo G., Carini R., Biasi E., Poli G., and Dianzani M. U. (1985). Mechanisms responsible for carbon tetrachloride-induced perturbation of mitochondrial calcium homeostasis. FEBS Lett 192: 184-188.
3. Alvaro D., Gigliozzi A., Piat C., Carli L., Fraioli F., Romeo R., Francia C., Attili A. F. and Capocaccia L. (1997). Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/CO-3 exchanger in rat. J Hepatol 26: 146-157.
4. Barón V. and Muriel P. (1999). Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim Biophys Acta 1472: 173-180.
5. Benedetti A., Comporti M. and Esterbauer H. (1980). Identification of 4-hydroxy nonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620: 281-296.
6. Benedetti A., Comporti M., Fulceri R. and Esterbauer H. (1984). Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids: identification of 4,5-dihydroxydecenal. Biochim Biophys Acta 792: 172-181.
7. Berger L. M., Bhatt H., Combes B. and Estabrock R. W. (1986). CCl4-induced toxicity in isolated hepatocytes: the importance of direct solvent injury. Hepatology 6: 36-45.
8. Boros P. and Bromberg J. S. (2006). New cellular and molecular immune pathways in ischemia/ reperfusion injury. Am J Transplan 6: 652-658.
9. Bosard R., Stieger B., O'Neill B., Fricker G. and Meier P. J. (1993). Ethynylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 91: 2714-2720.
10. Bozza M., Bliss J. L., Maylor R., Erickson J., Donnelly L., Bouchard P., Dorner A. J. and Trepiccho W. L. (1999). Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30: 1441-1447.
11. Cameron G. R. and Hasan S. M. (1958). Disturbances of structure and function in the liver as the result of biliary obstruction. J Pathol Bacteriol 75: 333-349.
12. Cameron G. R. and Karunaratne W. A. E. (1932). Carbon tetrachloride cirrhosis in relation to liver regeneration. J Pathol Bacteriol 42: 1-21.
13. Cameron G. R. and Oakley C. L. (1932). Ligation of the common bile duct. J Pathol Bacteriol 35: 769-798.
14. Casillas-Ramí{dotless}rez A., Mosbah I. B., Ramalho F., Roselló-Catafau J. and Peralta C. (2006). Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79: 1881-1894.
15. Cedillo A., Mourelle M. and Muriel P. (1996). Effect of colchicine and trimethylcolchicinic acid on CCl4-induced cirrhosis in the rat. Pharmacol Toxicol 79: 241-246.
16. Chavez E., Alcantar L. K., Moreno M. G. and Muriel P. (2006). Gadolinium chloride inhibits the spontaneous resolution of fibrosis in CCl4-induced cirrhosis. Toxicol Mechan Meths 16: 1-7.
17. Cieslak P. R., Virgin IV H. W. and Stanley S. L. (1992). A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica. J Exp Med 176: 1605-1609.
18. Clawson G. A., MacDonald J. andWoo C. (1987). Early hypomethylation of 2'-O-ribose moieties in hepatocyte cytoplasmic ribosomal RNA underlies the protein synthetic defect produced by CCl4. J Cell Biol 105: 705-711.
19. Comporti M. (1985). Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 53: 599-623.
20. Daniel P. M., Prichardt M. L. and Reynoll P. C. (1952). The portal circulation in experimental cirrhosis of the liver. J Pathol Bacteriol 64: 53-60.
21. DiRenzo A. B., Gandolfi A. J. and Sipes I. G. (1982). Microsomal bioactivation and covalent binding of aliphatic halides to DNA. Toxicol Lett 11: 243-252.
22. Esterbauer H., Cheeseman K. H., Dianzani M. U., Poli G. and Slater T. F. (1982). Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochem J 208: 129-140.
23. Esterbauer H., Schaur R. J. and Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
24. Faggioni R., Jones-Carson J., Reed D. A., Dinarello C. A., Feingold K. R., Grunfeld C. and Fantussi G. (2000). Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 97: 2367-2372.
25. Fernandez G., Villaruel M. C., De Toranzo E. G. D. and Castro J. A. (1982). Covalent binding of carbon tetrachloride metabolites to the heme moiety of cytochrome P450 and its degradation products. Res Commun Chem Pathol Pharmacol 35: 283-290.
26. Fernández-Martí{dotless}nez E., Morales-Rí{dotless}os M. S., Pérez-Á lvarezV. and Muriel P. (2001). Effects of thalidomide and 3-pthalimido-3-(3,4-dimethoxyphenyl)-propanamide on bile duct obstruction-induced cirrhosis in the rat. Drug Dev Res 54: 209-218.
27. Fernandez-Martinez E., Perez-Alvarez V., Tsutsumi V., Shibayama M. and Muriel P. (2006). Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Exp Toxicol Pathol 58: 49-58.
28. Francis G. A, Fayard E., Picard F. and Auwerx J. (2003). Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
29. French S. W., Miyamoto K. and Tsukamoto H. (1986). Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res 10: 135-195.
30. Forni L. G., Packer J. E., Slater T. F. and Willson R. L. (1983). Reaction of the trichloromethyl and halothane-derived peroxy radicals with unsaturated fatty acids: a pulse radiolysis study. Chem Biol Interact 45: 171-177.
31. Fuji K. (1997). Preventive effect of isofluran on destruction of cytochrome P450 during dehalogenation of carbon tetrachloride in guinea pig microsomes. Drug Metabol Drug Interact 14: 99-107.
32. Gantner F., Leist M., Lohse A. W., Germann P. G. and Tiegs A. (1995). Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
33. Glantzounis G. K., Salacinski H. J., Yang W., Davidson B. R. and Seifalian M. (2005). The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transplant 11: 1031-1047.
34. Gruebele A., Zawaski K., Kaplan D. and Novak R. F. (1996). Cytochrome P450 2E1- and cytochrome P450 2B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-κB transcription factor levels. Drug Metabol Disp 24: 15-22.
35. Grypioti A. D., Theocharis S. E., Demopoulos C. A., Papadopoulou-Daifoti Z., Basayiannis A. C. and Mykoniatis M. G. (2006). Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int 26: 97-105.
36. Guo G. L., Lambert G., Negishi M., Ward J. M., Brewer H. B. Jr, Kliewer S. A., González F. J. and Sinal C. J. (2003). Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278: 45062-45071.
37. Hartley D. P., Kolaja K. L., Reichard J. and Petersen D. R. (1999). 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol Appl Pharmacol 161: 23-33.
38. Hornstein B., Stamler L., Bianchi L. and Landmann L. (1992). Ethinylestradiol increases volume and decreased sinusoidal membrane surface in the rat liver: a stereological analysis. Hepatology 16: 217-223.
39. Hruszkewycz A. M., Glende E. A. and Recknagel R. O. (1978). Destruction of microsomal cytochrome P450 and glucose-6-phosphatase by lipids extracted from peroxidized microsomes. Toxicol Appl Pharmacol 46: 695-702.
40. Jaeschke H. (2005a). Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 1: 389-397.
41. Jaeschke H. (2005b). Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290: 1083-1088.
42. Jaeschke H. and Bajt M. L. (2006). Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 89: 31-41.
43. Jaruga B., Hong F., Sun S., Radaeva S. and Gao B. (2003). Crucial role of IL-4/STAT6 in T cellmediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171: 3233-3244.
44. Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R. and Brodie B. B. (1973). Acetaminophen-induced hepatic necrosis. II Role of covalent binding in vivo. J Pharmacol Exp Ther 187: 195-202.
45. Kan K. S., Monte M. J., Parslow R. A. and Coleman R. (1989). Oestradiol 17 beta-glucuronide increases tight-juntional permeability in rat liver. Biochem J 261: 297-300.
46. Kono H., Rusyn I., Bradford B. U., Connor H. D., Mason R. P. and Thurman R. G. (2000). Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Ther 293: 296-303.
47. Kountouras J., Barbara H., Billing H. and Scheuer P. J. (1984). Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65: 305-311.
48. Kumar V., Deo M. G. and Ramalingaswami V. (1972). Mechanism of fatty liver in protein deficiency. An experimental study in the rhesus monkey. Gastroenterology 62: 445-451.
49. Kyung-Hyun K., Hyun-Chul K., Mee-Yul H., Hoon-Kyu O., Tae Sung L., Young Chae C., Ho-Jung S., Nam-Hee W. and Kwan-Kyu P. (2006). The antifibrotic effect of TGF-β1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Common 343: 1072-1078.
50. Lamson P. D. andWing R. (1926). Early cirrhosis of the liver produced in dogs by carbon tetrachloride. J Pharmacol Exp Therap 29: 191-202.
51. LeeW. M. (2004). Acetaminophen and the US Acute Liver Study Group: lowering the risks of hepatic failure. Hepatology 40: 6-9.
52. Lee J. M., Trauner M., Soroka C. J., Stieger B., Meier P. J. and Boyer J. L. (2000). Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118: 163-172.
53. Li B., Sun R., Wei H., Gao B. and Tian Z. (2006). Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 43: 1211-1219.
54. Long R. L. and Moore L. (1986). Elevated cytosolic calcium in rat hepatocytes exposed to carbon tetrachloride. J Pharmacol Exp Ther 238: 186-191.
55. Louis H., Le Moine O., Peny M. O., Quertinmont E., Fokan D., Goldman M. and Deviere J. (1997). Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 25: 1382-1389.
56. Manno M., Ferrara R., Cazzaro S., Rigotti P. and Ancona E. (1992). Suicidal inactivation of human cytochrome P-450 by carbon tetrachloride and halotane in vitro. Pharmacol Toxicol 70: 13-18.
57. McCay P. B., Lay E. K., Poyer J. L., DuBose C. M. and Jansen E. G. (1984). Oxygen and carboncentered free radical formation during carbon tetrachloride metabolism. J Biol Chem 259: 2135-2143.
58. Medina J. F., Martinez-Anso E., Vazquez J. J. and Prieto J. (1997). Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 25: 12-17.
59. Meyers M., Slikker W. and Vore M. (1980). Characterization of cholestasis induced by estradiol-17beta-d-glucuronide in the rat. J Pharmacol Exp Ther 214: 87-93.
60. Mico B. A. and Pohl L. R. (1983). Reductive oxygenation of carbon tetrachloride: trichloromethyl peroxy radical as a possible intermediate in the conversion of carbon tetrachloride to electrophilic chlorine. Arch Biochem Biophys 225: 596-609.
61. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R. and Brodie B. B. (1973a). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187: 185-194.
62. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R. and Brodie B. B. (1973b). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211-217.
63. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Sato S., Niwa M., Senoh H. and Fujiwara H. (1994). T-cell activation-associated hepatic-injury: mediation by tumor necrosis factor and protection by interleukin 6. J Exp Med 179: 1529-1537.
64. Morel P., Tallineau C., Pontcharraud R., Piriou A. and Huguet F. (1998). Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+, K+-ATPase activity in rat striatal synaptosomes. Neurochem Int 33: 531-540.
65. Moreno M. G. and Muriel P. (2006). Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice. J Appl Toxicol 26: 326-332.
66. Muriel P. (1997). Peroxidation of lipids and liver damage, in S. I. Baskin and H. Salem (eds), Oxidants and Free Radicals, Taylor & Francis, Washington, DC, USA, 237-257.
67. Muriel P. (2006). Role of nitric oxide in liver disorders, in S. Ali, D. Mann and S. L. Friedman (eds), Liver Diseases: Biochemical Mechanisms and NewTherapeutic Insights, Science Publishers, Enfield, NH, USA, 115-131.
68. Muriel P. (2007). Cytokines in liver diseases, S. C. Sahu (eds), in Hepatotoxicity: from Genomics to in vitro and in vivo Models, John Wiley & Sons Ltd, Chichester, UK
69. Muriel P. and Escobar Y. (2003). Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J Appl Toxicol 23: 103-108.
70. Muriel P. and Mourelle M. (1990). The role of membrane composition in ATPases activities of cirrhotic rats. Effect of silymarin. J Appl Toxicol 10: 281-284.
71. Muriel P. and Mourelle M. (1992a). Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosyl-L-methionine. J Hepatol 14: 16-21.
72. Muriel P. and Mourelle M. (1992b). The role of membrane composition in ATPase activities of cirrhotic rat liver: Effect of silymarin. J Appl Toxicol 10: 281-284.
73. Muriel P. and Mourelle M. (1992c). Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 10: 275-279.
74. Muriel P. and Suárez O. R. (1994). Role of lipid peroxidation on biliary obstruction in the rat. J Appl Toxicol 14: 423-426.
75. Muriel P., Garciapiña T., Pérez-Alvarez V. and Mourelle M. (1992). Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol 12: 439-442.
76. Muriel P., Fernández-Martí{dotless}nez E., Pérez-Á lvarez V., Lara-Ochoa F., Ponce S., Garcí{dotless}a J., Shibayama M. and Tsutsumi V. (2003). Thalidomide ameliorates CCl4-cirrhosis in the rat. Eur J Hepatol Gastroenterol 15: 951-957.
77. Muriel P., Moreno M. G., Hernández M. C., Chávez E. and Alcazar L. K. (2005). Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of the treatment: effect of silymarin, silibinin, colchicine and trimethylcolchinic acid. Basic Clin Pharmacol & Toxicol 96: 275-280.
78. Nicoletti F., Di Marco R., Zaccone P., Salvaggio A., Magro G., Bendtzen K., and Moroni P. (2000). Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 32: 728-733.
79. Nicotera P., Bellomo G. and Orrenius S. (1992). Calcium mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32: 449-470.
80. Nieuwenhuijs V. D., De Bruijn M. T., Padbury R. T., and Barritt G. T. (2006). Hepatic ischemiareperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci 51: 1087-1102.
81. Omura M., Katsumata T., Misawa H. and Yamaguchi M. (1999). Decrease in protein kinase and phosphatase activities in the liver nuclei of rats exposed to carbon tetrachloride. Toxicol Appl Pharmacol 160: 192-197.
82. Parola M., Albano E., Autelli R., Barrera G., Biocca M. E., Paradisi L. and Dianzani M. U. (1990). Inhibition of the high affinity Ca2+-ATPase activity in rat liver plasma membranes following carbon tetrachloride intoxication. Chem Biol Interact 73: 103-119.
83. Pascher A. and Klupp J. (2005). Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors? BioDrugs 19: 211-231.
84. Pérez-Tamayo R. (1983). Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology 3: 112-120.
85. Poli G., Chiarpotto E., Biasi F., Leonarduzzi G., Comoglio A., Albano E. and Dianzani M. U. (1989). Role of aldehydes in the propagation of lipid peroxidation-induced liver toxicity. Adv Biosci 76: 73-81.
86. Radaeva S., Sun R., Pan H. N., Hong F. and Gao B. (2004). Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342.
87. Rao S. B., Young R. A. and Mehendale H. M. (1989). Hepatic polyamines and related enzymes following chlordecone-potentiated carbon tetrachloride toxicity in rats. J Biochem Toxicol 4: 55-63.
88. Recknagel R. O., Glende E. A. Jr, Dolak J. A. and Waller R. L. (1989). Mechanism of carbon tetrachloride toxicity. Pharmacol Ther 43: 139-154.
89. Reinertson J. W. and Thompson P. E. (1951). Experimental amebic hepatitis in hamsters. Proc Soc Exp Biol Med 76: 518-520.
90. Rodrí{dotless}guez-Garay E. A. (2003). Cholestasis: human disease and experimental animal models. Ann Hepatol 2: 150-158.
91. Ruchirawat M., MostafaM. H., Shank R. C., andWeisburger E. K. (1983). Inhibitory effects of carbon tetrachloride on diethylnitrosamine metabolism and DNA alkylation. Carcinogenesis 4: 537-539.
92. Schreiber A. J. and Simon F. R. (1983). Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 3: 607-613.
93. Shibayama-Salas M., Navarro-Garcí{dotless}a F., López-Revilla R., Martí{dotless}nez-Palomo A. and Tsutsumi V. (1997). In vivo and in vitro intestinal amebiasis in gerbils. Parasitol Res 83: 170-176.
94. Simon F. R., Fortune J., Iwahashi M., Gartung C., Wolkoff A. and Sutherland E. (1996). Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 271: G1043-G1052.
95. Sinal C. J., Tohkin M., Miyata M., Ward J. M., Lambert G. and Gonzalez F. J. (2000). Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744
96. Sotelo-Félix J. I., Martí{dotless}nez-Fong D. and Muriel P. (2002). Protective effect of carnosol on CCl4-induced acute liver damage in rats. Eur J Gastronterol Hepatol 14: 1001-1006.
97. Spiegel H. U. and Bahde R. (2006). Experimental models of temporary normothermic liver ischemia. J Invest Surg 19: 113-123.
98. Sundari P. N. and Ramakrishna B. (1997). Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat? Biochim Biophys Acta 1362: 169-176.
99. Susin S. A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Constantini P., Ferri K. F., Irinopoulou T., Prevost M. C., Brothers G., Mak T. W., Penninger J., Earnshaw W. C. and Kroemer G. (2000). Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580.
100. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H. and Okumura K. (2000). Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97: 5498-5503.
101. Tanyuksel M. and Petri W. A. (2003). Laboratory diagnosis of amebiasis. Clin Microbiol Rev 16: 713-729.
102. Tiegs G., Hentschel J. and Wendel A. (1992). A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90: 196-203.
103. Tomasi A., Albano E., Bani S., Botti B., Corongiu F., Dessi M. A., Lannone A., Vannini V. and Dianzani M. U. (1987). Free radical metabolism of carbon tetrachloride in rat liver mitochondria. Biochem J 246: 313-317.
104. Trams E. G. and Symeonidis S. (1957). Morphologic and functional changes in the livers of rats after ligation or excision of the common bile duct. Am J Pathol 33: 13-27.
105. Trible D. L., Aw T. Y., and Jones D. P. (1987). The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 7: 377-386.
106. Tsokos-Kuhn J. O., Todd E. L., McMillin-Wood J. B. and Mitchell J. R. (1985). ATP-dependent calcium uptake by rat liver plasma membrane vesicles. Effect of alkylating hepatotoxins in vivo. Mol Pharmacol 28: 56-61.
107. Tsukamoto H. Reidelberger R. D., French S. W. and Largman C. (1984). Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am. J. Physiol 247: 595-599.
108. Tsukamoto H., Towner S. J., Ciofalo L. M. and French S. W. (1986). Ethanol-induced liver fibrosis in rats fed high-fat diet. Hepatology 6: 814-822.
109. Tsukamoto H., Gaal K. and French S. W. (1990). Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology 12: 599-608.
110. Tsutsumi V. and Martí{dotless}nez-Palomo A. (1988). Inflammatory reaction in experimental hepatic amebiasis. An ultrastructural study. Am J Pathol 130: 112-119.
111. Tsutsumi V. and Shimayama M. (2006). Experimental amebiasis: a selected review of some in vivo models. Arch Med Res 37: 210-220.
112. Tsutsumi V., Mena-López R., Anaya-Velázquez F. and Martí{dotless}nez-Palomo A. (1984). Cellular bases of experimental amebic liver abscess formation. Am J Pathol 117: 81-91.
113. Ueda K., Kobayashi S., Morita J. and Komano T. (1985). Site-specific damage caused by lipid oxidative products. Biochim Biophys Acta 824: 341-348.
114. van Loo G., Schotte P., van Gurp M., Demol H., Hoorelbeke B., Gevaert K., Rodriguez I., Ruiz-Carrillo A., Vandekerckhove J., Declercq W., Beyaert R., Vandenabeele P. (2001). Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independentDNAdegradation. Cell Death Differ 8: 1136-1142.
115. Varela-Moreiras G., Alonso-Aperte E., Rubio M., Gasso M., Deulofem R., Alvarez L., Caballeria J., Rodes J. and Mato J. M. (1995). Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation. Hepatology 22: 1310-1315.
116. Ventura-Juárez J., Campos-Rodrí{dotless}guez R. and Tsutsumi V. (2002). Early interactions of Entamoeba histolytica trophozoites with parenchimal and inflammatory cells in the hamster liver: an immunocytochemical study. Can J Microbiol 48: 123-131.
117. Weber L.W. D., Boll M. and Stampfl A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33: 105-136.
118. Williams R. (2006). Global challenges in liver disease. Hepatology 44: 521-526.
119. Yamamoto Y., Moore R., Hess H. A., Guo G. L., González F. J., Korach K. S., Maronpot R. R. and Negishi M. (2006). Estrogen receptor α mediates 17α-ethynylestradiol causing hepatotoxicity. J Biol Chem 281: 16625-16631.
120. Yoshida T., Adachi E., Nigi H., Fujii S. and Yanagi M. (1999). Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CCl4 in cynomolgus monkeys.Pathology 31: 29-35.
121. Zangar R. C., Benson J. M., Burnett V. L. and Springer D. L. (2000). Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes. Chem Biol Interact 15: 233-243.
122. Zawaski K., Gruebele A., Kaplan D., Reddy S., Mortensen A. and Novak R. F. (1993). Evidence for enhanced expression of c-fos, c-jun and the Ca(2+)-activated neutral protease in rat liver following carbon tetrachloride administration. Biochem Biophys Res Commun 197: 585-590.
123. Zimmerman H. J. (1999). Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver, Lippincott Williams & Wilkins, Philadelphia, PA, USA.